Initiator–particle synergy enables microrough, osteoconductive polymethyl methacrylate bone cement
Acta Biomaterialia · 2026-04 · 214 · 119-142
DOI: 10.1016/j.actbio.2026.03.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-04. Verfasst von Juri Saruta und 27 weiteren Autor:innen. Beteiligte Einrichtung: Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA; Division of Education Planning, School of Dentistr…. Hauptthemen laut MEDLINE: Polymethyl Methacrylate, Bone Cements, Bone Regeneration. Die Arbeit nennt 139 Literaturangaben. Gefördert von: Mitsui & Co Ltd.
Abstract (Originalsprache)
Conventional polymethyl methacrylate (PMMA) bone cement formulated with benzoyl peroxide (BPO) initiator is biotolerant, cytotoxic, and incapable of true osseointegration. Here, we introduce a transformative surface-engineering strategy that confers controlled microroughness and enhanced biocompatibility to PMMA bone cement through a synergistic combination of tri-n-butyl borane (TBB) as a polymerization initiator and optimized polymer particle size. Formulating PMMA-TBB with 10-20 µm particles generated hemispherical micro-protrusions that increased surface area by 68% (Sdr), compared with only 8% for conventional PMMA-BPO. TBB's rapid, oxygen-insensitive polymerization preserved particle contours and reduced free radical generation by ∼90%, markedly mitigating polymerization-induced cytotoxicity. The microrough PMMA-TBB supported significantly greater osteoblast attachment, proliferation, and differentiation in vitro, uniquely induced contact osteogenesis in vivo with concomitant upregulation of osteogenic genes, and yielded a 4-6-fold increase in bone-cement interfacial strength. Importantly, PMMA-TBB also enhanced endothelial cell adhesion and function, indicating a more permissive microenvironment for angiogenic-osteogenic coupling at the bone-cement interface. This initiator-particle design principle establishes PMMA-TBB as the first microrough PMMA bone cement with genuine osteoconductive and osseointegrative properties, shifting PMMA fixation from a passive, biotolerant paradigm toward biologically active integration in orthopedic surgery. STATEMENT OF SIGNIFICANCE: Polymethyl methacrylate (PMMA) bone cement has remained essentially unchanged for decades, functioning as a biotolerant filler with no true capacity for osseointegration. This study overturns that paradigm by introducing an initiator-particle synergy that enables, for the first time, controlled microroughness engineering in PMMA bone cement. By pairing tri-n-butyl borane (TBB) polymerization initiator with optimally sized polymer particles, we achieved hemispherical micro-protrusions that preserved particle contours, reduced free radical toxicity, and created a biologically active interface. The resulting PMMA-TBB cement uniquely induced contact osteogenesis and significantly strengthened bone-cement integration. This work establishes a transformative design principle for orthopedic biomaterials, shifting PMMA bone cement from passive fixation toward bioactive, osteoconductive integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA; Division of Education Planning, School of Dentistry, Kanagawa Dental University, Yokosuka, Japan.
- Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA; Department of Oral Pathology/Forensic Odontology, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.
- Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA.
- Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA; Department of Periodontology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
- Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA; Department of Orthodontics, Aichi Gakuin University School of Dentistry, Nagoya, Japan.
- Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA; Department of Fixed Prosthodontics, Kanagawa Dental University, Yokosuka, Japan.
Förderung
- Mitsui & Co Ltd
Zitieren
APA
Saruta, J., Sugita, Y., Kitajima, H., Matsuura, T., Hamajima, K., Saita, M., Shibata, R., Torii, Y., Kido, D., Ozawa, R., Sato, N., Sato, T., Ishijima, M., Sekiya, T., Okubo, T., Komatsu, K., Suzumura, T., Chen, P. C., Yoneda, A., …, & Ogawa, T. (2026). Initiator–particle synergy enables microrough, osteoconductive polymethyl methacrylate bone cement. Acta Biomaterialia, 214, 119-142. https://doi.org/10.1016/j.actbio.2026.03.025
Vancouver
Saruta J, Sugita Y, Kitajima H, Matsuura T, Hamajima K, Saita M, et al. Initiator–particle synergy enables microrough, osteoconductive polymethyl methacrylate bone cement. Acta Biomaterialia. 2026;214:119-142. doi:10.1016/j.actbio.2026.03.025
BibTeX
@article{Saruta2026,
author = {Saruta, Juri and Sugita, Yoshihiko and Kitajima, Hiroaki and Matsuura, Takanori and Hamajima, Kosuke and Saita, Makiko and Shibata, Rune and Torii, Yasuyoshi and Kido, Daisuke and Ozawa, Ryotaro and Sato, Nobuaki and Sato, Takuma and Ishijima, Manabu and Sekiya, Takeo and Okubo, Takahisa and Komatsu, Keiji and Suzumura, Toshikatsu and Chen, Po-Chun and Yoneda, Akiko and Saito, Natsumi and Sakaguchi, Wakako and Haga, Shugo and Nakano, Yuki and Kimoto, Katsuhiko and Lee, Masaichi Chang-Il and Miyazawa, Ken and Maeda, Hatsuhiko and Ogawa, Takahiro},
title = {Initiator–particle synergy enables microrough, osteoconductive polymethyl methacrylate bone cement},
journal = {Acta Biomaterialia},
year = {2026},
volume = {214},
pages = {119--142},
doi = {10.1016/j.actbio.2026.03.025}
}
EUVIMED